ELLX.F Stock Overview
Through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Elixinol Wellness Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0032 |
| 52 Week High | AU$0.021 |
| 52 Week Low | AU$0.0003 |
| Beta | 2.28 |
| 11 Month Change | 23.08% |
| 3 Month Change | 60.00% |
| 1 Year Change | -67.35% |
| 33 Year Change | -94.67% |
| 5 Year Change | -99.55% |
| Change since IPO | -99.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| ELLX.F | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 11.1% | 4.3% | 2.2% |
| 1Y | -67.3% | -12.0% | 31.6% |
Return vs Industry: ELLX.F underperformed the US Personal Products industry which returned -12% over the past year.
Return vs Market: ELLX.F underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| ELLX.F volatility | |
|---|---|
| ELLX.F Average Weekly Movement | 313.7% |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ELLX.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ELLX.F's weekly volatility has increased from 209% to 314% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | n/a | www.elixinolwellness.com |
Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021.
Elixinol Wellness Limited Fundamentals Summary
| ELLX.F fundamental statistics | |
|---|---|
| Market cap | US$5.70m |
| Earnings (TTM) | -US$4.46m |
| Revenue (TTM) | US$7.53m |
0.8x
P/S Ratio-1.3x
P/E RatioIs ELLX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELLX.F income statement (TTM) | |
|---|---|
| Revenue | AU$11.59m |
| Cost of Revenue | AU$7.46m |
| Gross Profit | AU$4.13m |
| Other Expenses | AU$11.00m |
| Earnings | -AU$6.87m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0039 |
| Gross Margin | 35.65% |
| Net Profit Margin | -59.27% |
| Debt/Equity Ratio | 11.9% |
How did ELLX.F perform over the long term?
See historical performance and comparison